Filter announcements
Loading...
Accretion Pharmaceuticals Limited, established in 2012, produces and sells tablets, capsules, and healthcare products, offering both generic and branded formulations. It provides contract manufacturing services for domestic and international clients, including government and private institutions.
Accretion Pharma clarified IPO fund utilization, confirming Rs 27.75 Cr out of Rs 29.75 Cr raised was used for prospectus objectives. Auditors certified this utilization. The balance Rs 2.00 Cr is in deposits, confirming compliance regarding IPO funds.